Skip to NavigationSkip to content


Teva donates millions of hydroxychloroquine sulfate tablets, touted by Trump as coronavirus treatment

Photo by Gage Skidmore

Teva pharmaceuticals have said they will provide ten million doses of its anti-malaria drug hydroxychloroquine, which President Trump has been promoting as an effective coronavirus treatment.

Six million of these doses will be delivered to the US by 31 March. Teva Executive Vice President Brendan O’Grady said: “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost.”

Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims

Image Credit: Gage Skidmore,

President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the potential impact of the virus before finally declaring a state of national emergency on 13 March, the US President came under fire just days later after it was confirmed he had attempted to solicit the pharmaceutical industry to develop a coronavirus vaccine exclusively for US patients.

German biopharma firm CureVac is one of a number of industry firms currently hard at work developing a vaccine for the COVID-19 coronavirus.

Trump meets pharmaceutical executives to discuss COVID-19 vaccine

Official White House Photo by Shealah Craighead

President Trump has met with several representatives of the top pharmaceutical companies to discuss progress being made on a coronavirus vaccine.

Executives from Gilead Sciences, GlaxoSmithKline, Inovio pharmaceuticals, Moderna and Regeneron Pharmaceuticals were all in attendance.

How do the Presidential frontrunners plan to combat the opioid crisis?

Published on 12/02/20 at 12:58pm

The widespread addiction to extremely potent, legal painkillers has decimated the lives of millions across the United States. Overdoses from opioids have surpassed car crashes and gun violence as the leading cause of death in Americans under the age of 55. The epidemic has killed nearly 400,000 people since 2000 – more people than HIV at the peak of that disease – while its economic cost has been placed between $50 billion and $1 trillion.

Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of certain drugs, with or without the help of Congress.

Both Senator Elizabeth Warren of Massachusetts and Senator Amy Klobuchar of Minnesota, said they would act independently of Congress and said that the powers of the presidency means they have the legal authority to rein in prices without Congressional action.

Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020

Multiple drugmakers, including Pfizer, Sanofi and GlaxoSmithKline, plan to increase US list prices on more than 200 drugs in the United States.

Most price increases are expected to be announced later this week. Most will be below 10 percent and around half of them will be in the 4-6 percent range, as most drugmakers have pledged to keep their price increases below 10 percent a year due to pressure from patients and politicians.

Trump administration takes steps to allow cheaper drug imports from Canada

The Trump administration is close to allowing the import of some prescription Canadian drugs into the country.

The FDA and the Department of Health and Human Services (HHS) announced that it will introduce a notice of proposed rulemaking. This is how the administration will ask states to lay out how they would work with pharmacies and other parties to bring in drugs from Canada.

The FDA will seek a request for comment on two possible ways states could act.

Trump’s new FDA nominee advances in the Senate

Dr Stephen Hahn, President Donald Trump’s FDA nominee, has advanced his nomination to the full Senate chamber.

The vote was decided 18-5 by the Senate’s Health, Education, Labour and Pensions (HELP) committee, and this likely means that Hahn will be confirmed by the entire Senate. 

Jeremy Corbyn writes Trump letter asking for reassurance over NHS in trade deal

Labour Party leader Jeremy Corbyn has written to US President Donald Trump demanding he confirm that he will not put up drug prices in a UK-US post-Brexit trade deal.

Majority of British people worried about the fate of the NHS in post-Brexit US trade deal, survey reveals

In a newly released survey on “Over-The-Counter (OTC) and Pharma 2019”, by the business data platform Statista, 55% of people surveyed were concerned about the potential post-Brexit trade deal with the US and its impact on the NHS.

The survey assessed the responses of more than 2,000 British consumers. The NHS being part of a UK-US trade deal was first touted back in June by US Ambassador to the UK, Woody Johnson.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches